AMPAC Fine Chemicals LLC (AFC), a subsidiary of American Pacific
Corporation (Nasdaq: APFC), announced today that it has entered into a
business collaboration with Inabata & Co., Ltd. Japan (Inabata). The purpose
of the collaboration is to provide access to the Japanese pharmaceutical
market for the various technologies that AFC has developed for successfully
manufacturing active pharmaceutical ingredients (APIs). Through its vast
network and history in Japan, the agreement names Inabata as AFC’s exclusive agent to represent AFC in the country of Japan.
“We are excited about the collaboration with Inabata. They have a strong
track record of successfully pairing technologies with client needs and know
the Japanese marketplace well. Based on their years of experience, they have
the ability to identify Japanese partners that can benefit from the use of
AFC technologies. This collaboration will make a great team,” said Aslam
Malik, President of AFC.
“We are pleased and honored to enter into a partnership with AMPAC Fine
Chemicals,” stated Seikou Kuroutsu, General Manager of Inabata & Co., Ltd.
“AFC is renowned throughout the world for their expertise in Simulated Moving
Bed Separation (SMB) technology, Energetic Chemistry, HPAPIs, as well as the
proven ability to manufacture APIs at commercial scale. AFC’s extensive
technologies and expertise will enhance our customers’ API development and
scale-up efforts.”
“AMPAC Fine Chemicals is a leading manufacturer of custom small molecule
APIs,” stated Joe Carleone, Chief Executive Officer of AMPAC. “We are looking
forward to partnering with Inabata enabling our technical leadership to
support production of important drug substances for pharmaceutical customers
in Japan.”
ABOUT AMPAC FINE CHEMICALS LLC
AFC is a U.S.-based company with demonstrated capabilities in process
development, scale-up, and cGMP-compliant commercial production of active
pharmaceutical ingredients (API’s) and registered intermediates for
pharmaceutical and biotechnology customers. Its specially engineered
facilities and experienced staff allow AFC to safely produce highly energetic
compounds at commercial scale. In addition, AFC’s other technology platforms
include production of highly potent compounds, continuous processes and
industrial-scale chromatographic separation using simulated moving bed
chromatography (SMB).
ABOUT AMERICAN PACIFIC CORPORATION
American Pacific Corporation (AMPAC) is a leading custom manufacturer of
fine chemicals, specialty chemicals and propulsion products within its
focused markets. We supply active pharmaceutical ingredients and advanced
intermediates to the pharmaceutical industry. For the aerospace and defense
industry we provide specialty chemicals used in solid rocket motors for space
launch and military missiles. AMPAC also designs and manufactures liquid
propulsion systems, valves and structures for space and missile defense
applications. We produce clean agent chemicals for the fire protection
industry, as well as electro-chemical equipment for the water treatment
industry. Our products are designed to meet customer specifications and often
must meet certain governmental and regulatory approvals. Additional
information about us can be obtained by visiting our web site at
www.apfc.com.
ABOUT INABATA & CO., LTD.
Inabata & Co., Ltd is a Japanese trading company with innovative
solutions and services for information technology, electronics, chemicals,
plastics, housing materials and food enterprises worldwide.
The Chemicals Division of Inabata provides quality products and
information in a timely fashion in order to meet the needs of our customers,
taking advantage of its advanced expertise in performance chemicals and life
science as well as its global networks. With unrivalled speed and in close
partnership, we hope to be a partner who can offer “time and space
outsourcing services” for customers, assisting them in putting their
management resources to efficient use. The Chemicals Division responds to
broad-ranging needs, including production and logistics services.
Tapping into the wealth of achievements and experience accumulated since
our foundation, we are taking the lead in performance chemicals and life
science businesses as a dynamic developer of new opportunities.
FORWARD-LOOKING STATEMENTS
Statements contained in this press release that are not purely historical
are forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, including without
limitation statements regarding anticipated benefits and outcomes from the
collaboration of Ampac Fine Chemicals LLC with Inabata & Co., Ltd. and
statements regarding the anticipated impact of each company’s abilities and
expertise on future customers. The inclusion of forward-looking statements
should not be regarded as a representation by American Pacific Corporation
and its affiliates (collectively, “American Pacific”) that any of American
Pacific’s expectations will be achieved. Actual results may differ materially
from future results or outcomes expressed or implied by forward-looking
statements set forth in this press release due to risks, uncertainties and
other important factors inherent in American Pacific’s business. Factors that
might cause actual results to differ include, but are not limited to, those
included in the “Risk Factors” section of the Form 10-Q for the quarter ended
December 31, 2009 filed by American Pacific Corporation with the U.S.
Securities and Exchange Commission. Readers of this press release are
referred to the filings of American Pacific Corporation with the U.S.
Securities and Exchange Commission, including the Form 10-Q for the quarter
ended December 31, 2009 and the Form 10-K for the fiscal year ended September
30, 2009, for further discussion of these and other factors that could affect
future results. The forward-looking statements contained in this press
release are made as of the date hereof and American Pacific assumes no
obligation to update for actual results or to update the reasons why actual
results could differ materially from those projected in the forward-looking
statements, except as required by law.
SOURCE: American Pacific Corporation
CONTACT: Technical,
William DuBay, Ph.D.,
Vice President,
Technology and Business Development of AMPAC Fine Chemicals,
+1-800-311 9668, or
Investors,
Deanna Riccardi of American Pacific Corporation,
+1-702-735-2200
